Want to see IVF full AI Analyst Report?
INVO Fertility (IVF) Stock Forecast & Price Target
IVF Analyst Ratings
There are no analyst ratings in the last 3 months.
IVF Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | $20 | buy | 930.93%Upside | Upgraded | 02/10/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Jason McCarthyMaxim Group | BuyUpgraded$20 | 02/10/26 | 930.93%Upside |
Best Analysts Covering INVO Fertility
Copying DeepSeek Medical - Devices's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +40.12% per trade.
Copying DeepSeek Medical - Devices's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +39.28% per trade.
Copying DeepSeek Medical - Devices's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +39.28% per trade.
IVF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, IVF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IVF average Analyst price target in the past 3 months is ―.
IVF Financial Forecast
IVF Earnings Forecast
Next quarter’s earnings estimate for IVF is $1.40 with a range of ― to ―. The previous quarter’s EPS was $1.40. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IVF Sales Forecast
Next quarter’s sales forecast for IVF is $2.18M with a range of ― to ―. The previous quarter’s sales results were $2.18M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
